AFP and hepatocellular carcinoma: LT for patients with HCC outside the Milan range should be considered regardless of the morphological aspects, for well- to moderately differentiated tumours (G1 or G2 differentiation), without microscopic angioinvasion and with favourable AFP dynamics if preoperative bridging therapy can be performed.